CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance.
暂无分享,去创建一个
C. Bangma | S. Aluwini | L. Incrocci | W. Kirkels | I. Kolkman-Deurloo | Peter H E Van rooij | M. Hoogeman | Peter H. van Rooij